WINDTREE THERAPEUTICS INC /DE/
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | $198.0K | $1.8M |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | — | $16.3M | $8.3M | $11.1M | $17.8M | $15.4M | $12.7M | $10.6M |
| SG&A Expense | — | $8.7M | $9.2M | $10.8M | $14.5M | $14.9M | $12.4M | $7.4M |
| Operating Income | — | $-26.1M | $-20.6M | $-41.3M | $-77.3M | $-30.3M | $-24.9M | $-16.2M |
| Operating Margin | — | — | — | — | — | — | -12,572.2% | -905.8% |
| Interest Expense | — | — | $50.0K | $53.0K | $114.0K | $125.0K | $495.0K | $1.4M |
| Pretax Income | — | $-1.8M | $-20.3M | $-40.6M | $-77.6M | $-32.6M | — | — |
| Income Tax Expense | — | $-6.0K | $0 | $-1.4M | $-10.0M | $0 | — | — |
| Net Income | — | $-1.8M | $-20.3M | $-39.2M | $-67.6M | $-32.6M | $-27.5M | $-20.5M |
| Net Margin | — | — | — | — | — | — | -13,876.3% | -1,148.4% |
| EPS (Basic) | — | $-104.35 | $-393.24 | $-0.74 | $-1.63 | $-0.02 | $-0.03 | $-0.09 |
| EPS (Diluted) | — | — | — | — | $-0.03 | $-0.02 | $-0.03 | $-0.09 |
| Shares Outstanding (Basic) | 3.6M | 52.6M | 51.6M | 52.9M | 41.6M | 1.42B | 1.15B | 377.4M |
| Shares Outstanding (Diluted) | 3.6M | 52.6M | 51.6M | 52.9M | 41.6M | 1.42B | 1.15B | 377.4M |
| Dividends Per Share | — | — | — | — | — | — | — | — |